📜 Post with us on Reddit
📝 Create a new article
🏭 Create a company page
🇬🇧 - in English
🇫🇷 - en Français (FR)
🇵🇹 - em Português (PT)
🇩🇪 - auf Deutsch (DE)
🇯🇵 - 日本語で (JA)
Sponsored articles

You can edit almost every page by Creating an account and confirming your email.

Laprophan

From EverybodyWiki Bios & Wiki




Laprophan
Native name
Laboratoires de Produits Pharmaceutiques d'Afrique du Nord
Société anonyme
ISIN🆔
IndustryPharmaceuticals
Founded 📆1949
Founder 👔Abderrahim Bennis
Headquarters 🏙️,
Casablanca
,
Morocco
Area served 🗺️
Key people
Dr Farid Bennis (chairman & CEO); Reda Bennis (vice-president)
Members
Number of employees
🌐 Websitelaprophan.com
📇 Address
📞 telephone

Laprophan is a Moroccan pharmaceutical company founded in 1949 in Casablanca by Abderrahim Bennis.[1] The company manufactures and distributes medicines in Morocco and exports to markets in Africa and the Middle East.[2] Dr Farid Bennis has served as chairman and CEO since June 2020; he previously held the CEO position until 2011.[3][4]

History

Laprophan traces its origins to 1949 in Casablanca.[5] On 3 May 2011, CEO Farid Bennis resigned from his functions.[6] He returned as chairman and CEO following a board decision in June 2020.[7][8]

Ownership and financing

In 2023 a consortium led by Mediterrania Capital Partners (fund MC IV), alongside development finance institutions DEG, Proparco and FMO, made a minority investment in Laprophan, reported at about €75 million.[9][10][11][12]

Operations

Laprophan operates as a Moroccan société anonyme active in manufacturing, distribution, import and export of medicines, with export activity to more than 30 countries in Africa and the Middle East.[13]

Products

Laprophan markets prescription and over-the-counter medicines in several therapeutic areas. Selected brands include:

  • DI-INDO (indomethacin).[14]
  • IXOR (omeprazole).[15]
  • LEVAMOX (amoxicillin/clavulanic acid).[16]
  • NEOFORTAN (phloroglucinol).[17]

Acquisitions and expansion

  • Amanys Pharma – announced acquisition (10 November 2023), subject to regulatory approvals.[18][19]
  • AIF Pharma Maroc – Competition Council approved Laprophan's 100% acquisition (26 February 2024).[20][21]
  • Botanic Pharma – notification of planned acquisition of control (1 July 2024).[22]
  • Europhan – Laprophan announced a European platform branded Europhan (May 2024).[23]
  • Planned European acquisitions – notification of a joint acquisition (with investor Piero Luigi Umberto Poli) of 60% of Pian Holding BV, 60% of Double-e Pharma Limited and 60% of Rivopharm Limited (23 October 2025).[24]

Partnerships and recent developments

In 2023 Laprophan and Sinopharm signed a strategic cooperation agreement (10 February) and a memorandum of understanding focused on African markets (1 November).[25][26] In November 2025, Novo Nordisk and Laprophan announced the launch of semaglutide in Morocco.[27][28]

Legal matters

In March 2024 the Casablanca Commercial Court issued a first-instance ruling concerning the Fluocaril trademark, reported by business media.[29]

See also

References

  1. ↑ "Project detail – Laprophan". FMO – Dutch entrepreneurial development bank. 4 May 2023. Retrieved 11 November 2025.
  2. ↑ "Project detail – Laprophan". FMO. 4 May 2023. Retrieved 11 November 2025.
  3. ↑ "Un nouveau PDG pour Laprophan". L'Économiste (in français). 22 June 2020. Retrieved 11 November 2025.
  4. ↑ "Alerte : le PDG de Laprophan démissionne". Infomediaire (in français). 3 May 2011. Retrieved 11 November 2025.
  5. ↑ "Project detail – Laprophan". FMO. 4 May 2023. Retrieved 11 November 2025.
  6. ↑ "Alerte : le PDG de Laprophan démissionne". Infomediaire (in français). 3 May 2011. Retrieved 11 November 2025.
  7. ↑ "Nomination d'un nouveau P-DG à la tête de la Laprophan". Médias24 (in français). 22 June 2020. Retrieved 11 November 2025.
  8. ↑ "Farid Bennis nommé PDG de Laprophan". Le Matin (in français). 22 June 2020. Retrieved 11 November 2025.
  9. ↑ "Mediterrania Capital Partners, DEG, Proparco and FMO invest €75 million in Laprophan". Mediterrania Capital Partners. 11 May 2023. Retrieved 11 November 2025.
  10. ↑ "Mediterrania Capital Partners, DEG, Proparco et FMO investissent 75 millions d'euros dans Laprophan". Proparco (in français). 11 May 2023. Retrieved 11 November 2025.
  11. ↑ "DEG invests in Moroccan pharmaceutical company Laprophan". DEG. May 2023. Retrieved 11 November 2025.
  12. ↑ "Project detail – Laprophan". FMO. 4 May 2023. Retrieved 11 November 2025.
  13. ↑ "Project detail – Laprophan". FMO. 4 May 2023. Retrieved 11 November 2025.
  14. ↑ "DI-INDO 50 mg, comprimé effervescent". Medicament.ma (in français). Retrieved 11 November 2025.
  15. ↑ "IXOR 20 mg, comprimé effervescent". Medicament.ma (in français). Retrieved 11 November 2025.
  16. ↑ "LEVAMOX 1 g/125 mg, comprimé effervescent". Medicament.ma (in français). Retrieved 11 November 2025.
  17. ↑ "NEOFORTAN 160 mg, comprimé effervescent". Medicament.ma (in français). Retrieved 11 November 2025.
  18. ↑ "Laprophan annonce l'acquisition d'Amanys Pharma de SPE Capital et Proparco". TelQuel (in français). 10 November 2023. Retrieved 11 November 2025.
  19. ↑ "DLA Piper advises SPE Capital on the sale of Amanys Pharma to Laprophan". DLA Piper. 14 November 2023. Retrieved 11 November 2025.
  20. ↑ "Communiqué relatif à la réunion du 26 février 2024". Conseil de la concurrence (in français). 26 February 2024. Retrieved 11 November 2025.
  21. ↑ "Le Conseil de la concurrence approuve le rachat de AIF Pharma Maroc par Laprophan". Médias24 (in français). 28 February 2024. Retrieved 11 November 2025.
  22. ↑ "Communiqué – Projet de concentration Laprophan/Botanic Pharma" (PDF). Conseil de la concurrence (in français). 1 July 2024. Retrieved 11 November 2025.
  23. ↑ "Laprophan se lance sur le marché pharmaceutique européen avec Europhan". Médias24/LeBoursier (in français). 14 May 2024. Retrieved 11 November 2025.
  24. ↑ "Communiqué – Projet de concentration Laprophan/Pian Holding BV/Double-e Pharma Ltd/Rivopharm Ltd" (PDF). Conseil de la concurrence (in français). 23 October 2025. Retrieved 11 November 2025.
  25. ↑ "Accord stratégique entre Laprophan et Sinopharm". Médias24 (in français). 10 February 2023. Retrieved 11 November 2025.
  26. ↑ "Laprophan et Sinopharm s'allient pour conquérir le marché africain". Médias24 (in français). 1 November 2023. Retrieved 11 November 2025.
  27. ↑ "Maroc : Novo Nordisk et Laprophan lancent Sémaglutide". L'Économiste (in français). 6 November 2025. Retrieved 11 November 2025.
  28. ↑ "L'Ozempic officiellement lancé au Maroc, sur fond de controverse". Médias24 (in français). 5 November 2025. Retrieved 11 November 2025.
  29. ↑ "Bataille Laprophan/Unilever autour du dentifrice Fluocaril". Médias24 (in français). 14 March 2024. Retrieved 11 November 2025.

External links


This article "Laprophan" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Laprophan. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.


Retrieved from "https://en.everybodywiki.com/index.php?title=Laprophan&oldid=5530541"
License CC BY-SA 3.0
Powered by MediaWiki